Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Internet Tools and Emergency Attendance

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03881839
Recruitment Status : Recruiting
First Posted : March 20, 2019
Last Update Posted : March 25, 2019
Sponsor:
Information provided by (Responsible Party):
University Hospital, Clermont-Ferrand

Brief Summary:
Over the years, there has been an increase in the flow of emergency rooms, which is gradually leading to an overcrowding of emergency unit. This overcrowding is multifactorial with, for example, a decrease in the outpatient care in family medicine and specialized medicine, emergency services unsuitable at the level of premises ... In parallel, investigator note in recent years facilitated access to internet and especially to GAFA which is the acronym for Google, Amazon, Facebook, Apple. As a result, patients have 24-hour access to medical information via websites, blogs and social networks. This information of, often, unreliable medical information can lead to ambiguity among patients about the need for urgent or delayed intervention in the management of their symptoms. In fact, "everything becomes urgent". To date, in France, no study has evaluated the impact and prevalence of consulting a website for medical purposes before consulting an emergency service. The objective of this research will be to assess, in patients presenting in an emergency department, the prior consultation of medical information on a website, the impact on the emergency consultation decision and the relevance of this consultation.

Condition or disease Intervention/treatment
Emergency Other: emergency

Detailed Description:

It is an observational study, monocentric, prospective. This study consists in collecting data from an anonymized questioner given to patients presenting themselves at the emergency department of Clermont-Ferrand University Hospital. Answers to the questions will not change the patient's management. The questioner, containing 17 questions, requires answering "yes" or "no" by ticking boxes, or even specify when it is stipulated. This questionnaire will be given to the patient after his registration, and filled by the latter in the waiting room, pending medical care. Answering the questionnaire will take between 5 to 10 minutes. The data is anonymous.

The patient arrives at the emergency department and registers at the entrance desks where a paper and computer file is created. Then, the Reception and Orientation Nurse takes care of the patient by welcoming him in the reception box, she realizes the taking of the hemodynamics constants, the collection of the reason of consultation with the grievances of the patient. During this phase, patient will be inform of the completion of this study and asked to participate in this study. If the patient agrees to participate, an anonymized questioner will be provided and explained by one of the investigating physicians or associated partners.

Layout table for study information
Study Type : Observational
Estimated Enrollment : 431 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Impact of "Internet Tools" Consultation on Increasing Emergency Attendance
Actual Study Start Date : March 21, 2019
Estimated Primary Completion Date : March 2020
Estimated Study Completion Date : March 2020

Group/Cohort Intervention/treatment
patient in emergency department Other: emergency
The objective of this research will be to assess, in patients presenting in an emergency department, the prior consultation of medical information on a website, the impact on the emergency consultation decision and the relevance of this consultation.




Primary Outcome Measures :
  1. Rate of justified nature of the consultation between patient who did consult a website before the emergency room and those who didn't. [ Time Frame: at day 1 ]

    The comparison between the justification (or not) of the transition to adult emergencies and the consultation of an upstream website will be done using the Chi2 test (or Fisher's exact test if applicable).

    The search for criteria related to the justified nature of this emergency procedure will be done with the Chi2 test (or Fisher's exact test if applicable) for the categorical data and with the Student's test (or Mann and Whitney test if not normally distributed) for continuous data.



Secondary Outcome Measures :
  1. Prevalence of Internet consultation among patients admitted to emergency room [ Time Frame: at day 1 ]
    The rate of consultation of a website before the emergency room, will be expressed as a percentage with its 95% confidence interval

  2. The rate of justified consultation [ Time Frame: at day 1 ]
    The rate of justified consultation to emergency department, will be expressed as a percentage with its 95% confidence interval.

  3. Risk factors related to consultation of a website medical information prior to the transition to adult emergencies. [ Time Frame: at day 1 ]
    The comparison between patients who visited a medical information website (vs those who did not consult the internet) before the emergency department visit will be done using the same methods as for the analysis of the main criterion.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Any major patient presenting to the emergency department by their personal way.
Criteria

Inclusion Criteria:

  • Any major patient presenting to the emergency department by their personal way.

Exclusion Criteria:

  • Suspicion of acute alcoholism
  • dementia
  • guardianship / trusteeship
  • language barrier, non-communicating patient
  • patient refusing to participate in the study
  • patient with confusion
  • patient with Glasgow scale less than 15
  • patient not affiliated with social security
  • patient not knowing how to read or write.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03881839


Contacts
Layout table for location contacts
Contact: Lise LACLAUTRE 04 73 75 49 63 drci@chu-clermontferrand.fr

Locations
Layout table for location information
France
Chu Clermont-Ferrand Recruiting
Clermont-Ferrand, France, 63003
Contact: Lise LACLAUTRE    04 73 75 49 63    drci@chu-clermontferrand.fr   
Principal Investigator: Farès MOUSTAFA         
Sponsors and Collaborators
University Hospital, Clermont-Ferrand
Investigators
Layout table for investigator information
Principal Investigator: Farès MOUSTAFA University Hospital, Clermont-Ferrand
Layout table for additonal information
Responsible Party: University Hospital, Clermont-Ferrand
ClinicalTrials.gov Identifier: NCT03881839    
Other Study ID Numbers: CHU-431
2019 / CE 06 ( Other Identifier: 2019 / CE 06 )
First Posted: March 20, 2019    Key Record Dates
Last Update Posted: March 25, 2019
Last Verified: March 2019

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Emergencies
Disease Attributes
Pathologic Processes